Enhanced native chemical ligation by peptide conjugation in trifluoroacetic acid.

Publication date: Jul 19, 2024

Chemical ligation of peptides is increasingly used to generate proteins not readily accessible by recombinant approaches. However, a robust method to ligate “difficult” peptides remains to be developed. Here, we report an enhanced native chemical ligation strategy mediated by peptide conjugation in trifluoroacetic acid (TFA). The conjugation between a carboxyl-terminal peptide thiosalicylaldehyde thioester and a 1,3-dithiol-containing peptide in TFA proceeds rapidly to form a thioacetal-linked intermediate, which is readily converted into the desired native amide bond product through simple postligation treatment. The effectiveness and practicality of the method was demonstrated by the successful synthesis of several challenging proteins, including the SARS-CoV-2 transmembrane Envelope (E) protein and nanobodies. Because of the ability of TFA to dissolve virtually all peptides and prevent the formation of unreactive peptide structures, the method is expected to open new opportunities for synthesizing all families of proteins, particularly those with aggregable or colloidal peptide segments.

Concepts Keywords
Nanobodies COVID-19
Peptides Humans
Recombinant Peptides
Robust Peptides
Thiosalicylaldehyde SARS-CoV-2
Single-Domain Antibodies
Single-Domain Antibodies
Trifluoroacetic Acid
Trifluoroacetic Acid

Semantics

Type Source Name
disease VO report
disease VO effectiveness
disease MESH COVID-19

Original Article

(Visited 2 times, 1 visits today)